Iron deficiency in the fetus and newborn;Deficiência de ferro no feto e no recém-nascido

Revista Brasileira de Hematologia e Hemoterapia

Volumn 32, Issue SUPPL. 2, 2010, Pages 32-37

  Chopard, Maria Renata T ^a   Magalhães, Maurício ^a,b   Bruniera, Paula ^a,b  

^a Servico de Neonatologia Do Hospital   (Brazil)

^b Hematologia e Oncologia   (Brazil)

Author keywords

Anemia; Fetus; Iron; Iron deficiency; Newborn

Indexed keywords

EID: 78649622574     PISSN: 15168484     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1516-84842010005000051     Document Type: Review

References (47)

1. Scholl TO, Hediger ML. Anemia and iron-deficiency anemia: compilation of data on pregnancy outcome. Am J Clin Nutr. 1994. 59(2 Suppl):492S-500S.
2. Sifakis S, Pharmakides G. Anemia in pregnancy. Ann N Y Acad Sci. 2000;900:125-36.
3. Paiva AP, Rondó PHC, Pagliussi RA, Latorre MROO, Cardoso MAA, Gondim SSR. Relationship between the iron status of pregnant women and their newborns. Rev. Saúde Pública. 2007;41 (3):321-7.
4. Guyton AC: Tratado de fisiologia médica. 6a ed. Rio de Janeiro: Guanabara; 1986. p. 50-1.
5. Guidelines for transfusion of erythrocytes to neonates and premature infants. Fetus and Newborn Committee, Canadian Paediatric Society. CMJA. 1992;147(2):1781-92.
6. Dame C, Juul SE. The switch from fetal to adult erythropoiesis. Clin Perinatol. 2000;27(3):507-26.
7. Halperin DS. Use of recombinant erythropoietin in treatment of anemia of prematurity. Am J Pediatr Hematol Oncol. 1991;13(3): 351-63.
8. Jelkmann W. Biology of erythropoietin. Clin Investig. 1994;72(6 Suppl): S3-10.
9. Lackmann G.M, Schnieder C, Bohner J. Gestational age-dependent reference values for iron and selected proteins of iron metabolism in serum of premature human neonates. Biol. Neonate. 1998;74(3): 208-13.
10. Sigulem DM. Epidemiologia da anemia ferropriva na infância. Rev Soc Bras Hemat Hemot. 1988;10(149):103-7.
11. Vaz FAC. Contribuição ao estudo do metabolismo do ferro em recémnascidos prematuros no primeiro trimestre de vida [Tese Doutorado]. Faculdade de Medicina da Universidade de São Paulo;1971.
12. Strauss RG. Práticas da transfusão de eritrócitos no neonato. In: Bifano M, Ehrenkranz RA. Clínicas de Perinatologia: Hematologia Perinatal. vol 3. Rio de Janeiro: Interlivros; 1995. p. 643-57.
13. Fanaroff AA, Martin RJ. Neonatal, perinatal medicine. Diseases of the fetus and infants. 5 ed. St. Louis: Mosby - yearbook; 1992. p 941-2.
14. Geethanath RM, Ramji S, Thirupuram S, Rao YN. Effect of timing of cord clamping on the iron status of infants at 3 months. Indian Pediatr. 1997;34(2):103-6.
15. Gupta R, Ramji S. Effect of delayed cord clamping on iron stores in infants born to anemic mothers: a randomized controlled trial. Indian Pediatr. 2002;39(2):130-5.
16. Stockman III JA. Anemia of prematurity. Current concepts in the issue of when to transfuse. Pediatr Clin North Am. 1986;33(1): 111-28.
17. Dallman PR. Anemia of prematurity. Annu Rev Med. 1981;32: 143-60.
18. O'brien RT, Pearson HA. Physiologic anemia of the newborn infant. J Pediatr. 1971;79(1):132-8.
19. Saito T, Urabe A, Uramoto K, Hashimoto Y, Takaku F. Serum erythropoietin titres in the anaemia of premature infants. Br J Haematol. 1983;54(1):53-8.
20. Collard KJ. Iron homeostasis in the neonate. Pediatrics. 2009; 123(4):1208-16.
21. Joshi A, Gerhardt T, Shandloff P, Bancalari E. Blood transfusion effect on the respiratory pattern of preterm infants. Pediatrics. 1987;80(1):79-84.
22. Strauss RG. Transfusion therapy in neonates. Am J Dis Child. 1991;145(8):04-11.
23. Oski FA, Naiman JL, editors. Hematologic problems in the newborn. 3rd ed. Philadelphia: WB Saunders Co, 1982.
24. Avery GB. Neonatologia, fisiopatologia e tratamento do recémnascido. 2nd ed. Rio de Janeiro: Medsi; 1984. p. 553.
25. Shannon KM, Keith III JF, Mentzer WC, Ehrenkranz RA, Brown MS, Widness JA, et al. Recombinant human erythropoietin stimulates erythropoiesis and reduces erythrocyte transfusions in very low birth weight preterm infants. Pediatrics. 1995;95 (1):1-8.
26. Schiza V, Giapro V, Pantou K, Theocharis P, Chala A, Andronikous S. Serum transferring receptor, ferritin and reticulocyte maturity indices. Eur J Haematol. 2007;79(5):439-46.
27. Cook JD, Skikne BS, Baynes RD. Serum transferrin receptor. Annu Rev Med. 1993;44:63-74.
28. Punnonem K, Irjala K, Rajamaki A. Serum transferrin receptor and its ratio to serum ferritin in the diagnosis of iron deficiency. Blood. 1997;89(3):1052-7.
29. Cohen A, Manno C. Transfusion practices in infants receiving assisted ventilation. Clin Perinatol. 1998;25(1):97-111.
30. Rodrigues FPM, Berezin A, Percário S. Análise dos radicais livres de oxigênio no período neonatal pela medida dos níveis séricos de malondialdeído e sua correlação com a pO2 sanguínea. Arq méd Hosp Fac Ciênc Méd St Casa São Paulo. 2000;5(1).
31. Murray NA, Roberts IA. Neonatal transfusion practice. Arch Dis Child Fetal Neonatal Ed. 2004;89(2):101-7.
32. Kutner JM, Mota MA, Vacarini ALT, Bub RF. Manual de orientação para o uso de sangue, hemocomponentes e aféreses terapêuticas. 3rd ed. São Paulo: Atheneu; 2003.
33. Maier RF, Obladen MK, Kattner E, Natzschka J, Messer J, Regazzoni BM, et al. High-versus low-dose erythropoietin in extremely low birth weight infants. J Pediatr. 1998;132(5):866-70.
34. Ohls RK. The use of erythropoietin in neonates. In Christensen RD. Clin Perinatol. Neonatal Hematology. 2000;27(3):681-96.
35. Aher S, Ohlsson A. Late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants. Cochrane Database Syst Rev. 2006;3:CD004868.
36. Ohls RK, Ehrenkranz RA, Wright LL, Lemons JA, Korones SB, Stoll BJ, et al. Effects of early erythropoietin therapy on the transfusion requirements of preterm infants below 1250 grams birth weight: a multicenter, randomized, controlled trial. Pediatrics. 2001;108(4):934-42.
37. Pollak A, Hayde M, Hayn M, Herkner K, Lombard KA. Lubec G, et al. Effect of intravenous iron supplementation on erythropoiesis in erythropoietin-treated premature Infants. Pediatrics. 2001;107 (1):78-85.
38. Fuller NJ, Bates CJ, Cole TJ, Lucas A. Plasma folate levels in preterm infants, with and without a 1 mg daily folate supplement. Eur J Pediatr. 1992;151(1):48-50.
39. Young TE, Mangum B, Reuters T. Neofax. 21st ed. Montvale (NJ): Wiley-Blackwell; 2008. p. 296-313.
40. Arnon S, Shiff Y, Litmanovitz I, Regev RH, Bauer S, Shainkin-Kestenbaum R, et al. The efficacy and safety of early supplementation of iron polymaltose complex in preterm infants. Am J Perinatol. 2007;24(2):95-100.
41. Sankar MJ, Saxena R, Mani K, Agarwal R, Deorari AK, Paul VK. Early iron supplementation in very low birth weight infants--a randomized controlled trial. Acta Paediatr. 2009;98(6):953-8.
42. Jacobs P, Johnson G, Wood L. Oral iron therapy in human subjects, comparative absorption between ferrous salts and iron polymaltose. J Med. 1984;15(5-6):367-77.
43. Kavakli K, Yilmaz D, Cetinkaya B, Balkan C, Sözmen EY, Sagin FG. Safety profiles of Fe2+ and Fe3+ oral preparations in the treatment of iron deficiency anemia in children. Pediatr Hematol Oncol. 2004;21(5):403-10.
44. Tuomainen TP, Nyyssonen K, Porkkala-Sarataho E, Salonen R, Baumgartner JA, Geisser P, et al. Oral supplementation with ferrous sulfate but not with non-ionic iron polymaltose complex increases the susceptibility of plasma lipoproteins to oxidation. Nutrition Research. 1999;19:1121-32.
45. Messer J, Haddad J, Donato L, Astruc D, Matis J. Early treatment of premature infants with recombinant human erythropoietin. Pediatrics. 1993;92(4):519-23.
46. Widness JA, Serfass RE, Haiden N, Nelson SE. Erythrocyte iron incorporation but not absorption is increased by intravenous iron administration in erythropoietin-treated premature infants. J Nutr. 2006;136(7):1868-73.
47. Meyer MP, Haworth C, Meyer JH, Commerford A. A comparison of oral end intravenous iron supplementation in premature infants receiving recombinant erythropoietin. J Pediatr. 1996;129(2): 258-63.